[Problems in demonstrating protector-modified radioresistance. I. The deltap02 indication of the degree of mexamine-increased radioresistance of the rat bone marrow].
D008735:5-Methoxytryptamine / Q000494:pharmacology*; D000818:Animals; D001853:Bone Marrow / Q000187:drug effects* / Q000528:radiation effects; D001854:Bone Marrow Cells; D005609:Free Radicals; D000860:Hypoxia / Q000139:chemically induced; D008297:Male; D008722:Methods; D010101:Oxygen Consumption / Q000187:drug effects* / Q000528:radiation effects; D010313:Partial Pressure; D011836:Radiation Tolerance; D011837:Radiation-Protective Agents; D051381:Rats; D013997:Time Factors; D014363:Tryptamines / Q000494:pharmacology*
D005609:Free Radicals; D011837:Radiation-Protective Agents; D014363:Tryptamines; D008735:5-Methoxytryptamine
Voprosy indikatsii moditfitsirovannoi protektorami radiorezistentnosti. Soobshchenie I. Indikatsiia po del'tap02 stepeni povyshennoi meksaminom radiorezistentnosti kostnogo mozga krys.